Medieos Lifesciences LLP

Aceclofenac and Paracetamol combination is commonly used to relieve pain and inflammation in conditions like arthritis, back pain, toothache, and muscle pain. Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) that reduces inflammation and swelling, while Paracetamol helps lower fever and relieve pain. Together, they provide faster and more effective relief from pain and discomfort. This combination is often prescribed for joint and musculoskeletal disorders to improve mobility and comfort.

Lactulose is a synthetic sugar used primarily as a laxative to treat constipation and as a treatment for hepatic encephalopathy, a complication of liver disease. It works by drawing water into the colon, softening stools, and promoting regular bowel movements. Lactulose also helps reduce the absorption of ammonia in the gut, which is crucial for patients with liver failure, as excess ammonia can lead to confusion and cognitive issues.

In constipation, lactulose provides gentle relief without causing significant cramping or urgency, making it suitable for long-term use, especially in the elderly and those with chronic constipation. In hepatic encephalopathy, it lowers blood ammonia levels by converting ammonia to ammonium, which is then excreted.

Lactulose is generally safe, with mild side effects like bloating or flatulence. Its dual role in digestive and liver health makes it a valuable and versatile medication in both hospital and home care settings.

• Known hypersensitivity to Luliconazole or azole antifungals

• Severe skin conditions with open wounds (unless prescribed)

• Avoid use in systemic fungal infections

• Minimal systemic absorption → low risk of drug interactions

• Concurrent use with other topical medications should be supervised

• Avoid combination with strong corticosteroids unless prescribed

• Considered safe in topical use

• Use only on affected areas; consult physician

• Safe; avoid contact with infant’s skin

• Safe under dermatology supervision

• Adjust dose according to area and severity

• Well tolerated; monitor for skin sensitivity

• Store at 25°C or below

• Protect from light and moisture

• Keep in original tube and box

• Out of reach of children

For treating tinea infections, including tinea corporis, cruris, pedis, and superficial Candida infections.

Inhibits fungal lanosterol 14α-demethylase, disrupting fungal cell membranes and killing fungi.

Apply a thin layer to affected area once daily until infection resolves.

Yes, under pediatric dermatologist supervision.

Mild burning, redness, or itching may occur; severe reactions are rare.

Yes, topical use is considered safe; avoid application to breastfed areas.

Use other topical medications only under supervision; avoid strong corticosteroids.

Typically 1–2 weeks for tinea infections; continue until complete resolution.

Yes, bulk and institutional packs are available.

At 25°C, in original tube, away from light and moisture.

No, it is only for topical superficial infections.

Yes, Luliconazole’s high potency allows once-daily dosing, improving compliance.

Yes, under dermatologist guidance; may require prolonged therapy.

Yes, well tolerated; monitor for skin sensitivity.

Proper application and completion of the course reduce recurrence, along with hygiene measures.

• Known hypersensitivity to Luliconazole or azole antifungals

• Severe skin conditions with open wounds (unless prescribed)

• Avoid use in systemic fungal infections

• Minimal systemic absorption → low risk of drug interactions

• Concurrent use with other topical medications should be supervised

• Avoid combination with strong corticosteroids unless prescribed

• Considered safe in topical use

• Use only on affected areas; consult physician

• Safe; avoid contact with infant’s skin

• Safe under dermatology supervision

• Adjust dose according to area and severity

• Well tolerated; monitor for skin sensitivity

• Store at 25°C or below

• Protect from light and moisture

• Keep in original tube and box

• Out of reach of children

For treating tinea infections, including tinea corporis, cruris, pedis, and superficial Candida infections.

Inhibits fungal lanosterol 14α-demethylase, disrupting fungal cell membranes and killing fungi.

Apply a thin layer to affected area once daily until infection resolves.

Yes, under pediatric dermatologist supervision.

Mild burning, redness, or itching may occur; severe reactions are rare.

Yes, topical use is considered safe; avoid application to breastfed areas.

Use other topical medications only under supervision; avoid strong corticosteroids.

Typically 1–2 weeks for tinea infections; continue until complete resolution.

Yes, bulk and institutional packs are available.

At 25°C, in original tube, away from light and moisture.

No, it is only for topical superficial infections.

Yes, Luliconazole’s high potency allows once-daily dosing, improving compliance.

Yes, under dermatologist guidance; may require prolonged therapy.

Yes, well tolerated; monitor for skin sensitivity.

Proper application and completion of the course reduce recurrence, along with hygiene measures.

• Treats fungal skin infections like ringworm and tinea. 
• Helps reduce bacterial skin infections. 
• Relieves itching, redness, burning, and irritation.
•  Useful in inflammatory skin conditions with infection. 
• Helps prevent recurrence when used regularly as directed

• Complete biliary obstruction

• Acute gallbladder inflammation

• Known hypersensitivity to Ursodeoxycholic Acid

• Severe liver failure without specialist approval

• Cholestyramine / colestipol — may reduce absorption

• Aluminum hydroxide antacids — may interfere with absorption

• Estrogen-containing medications — can affect bile composition

Recommendation: Maintain at least a 2-hour gap between UDCA and interacting drugs.

• Only if benefits outweigh risks; supervised by a physician

• Minimal excretion in milk; caution advised

• Dose adjustment usually unnecessary; monitor liver function

• Weight-based dosing; supervised by a specialist

• Store below 25°C

• Protect from moisture and light

• Keep tablets in original packaging

• Keep out of reach of children

• Do not use after expiry date

• Complete biliary obstruction

• Acute gallbladder inflammation

• Known hypersensitivity to Ursodeoxycholic Acid

• Severe liver failure without specialist approval

• Cholestyramine / colestipol — may reduce absorption

• Aluminum hydroxide antacids — may interfere with absorption

• Estrogen-containing medications — can affect bile composition

Recommendation: Maintain at least a 2-hour gap between UDCA and interacting drugs.

• Only if benefits outweigh risks; supervised by a physician

• Minimal excretion in milk; caution advised

• Dose adjustment usually unnecessary; monitor liver function

• Weight-based dosing; supervised by a specialist

• Store below 25°C

• Protect from moisture and light

• Keep tablets in original packaging

• Keep out of reach of children

• Do not use after expiry date

Bilenta 150 Tablets are contraindicated in:

• Complete biliary obstruction

• Acute inflammation of gallbladder or bile ducts

• Hypersensitivity to Ursodeoxycholic Acid

• Non-functioning gallbladder

Ursodeoxycholic Acid may interact with:

• Cholestyramine and colestipol

• Aluminum-based antacids

• Estrogen-containing medicines

Spacing doses may reduce interaction risk.

Use only if clearly indicated and prescribed.

Generally considered safe under supervision.

No specific dose adjustment usually required.

Widely used with weight-based dosing.

• Store below 25°C

• Protect from moisture and light

• Keep out of reach of children

• Do not use after expiry date

It is used to treat liver and bile flow disorders.

A bile acid that protects liver cells and improves bile flow.

Yes, cholesterol gallstones.

Yes, under medical supervision.

Yes, as prescribed.

It manages and slows disease progression.

Mild diarrhea may occur.

Only if prescribed by a doctor.

Yes, with weight-based dosing.

Alcohol should be avoided.

No significant renal effects.

Improvement seen over weeks to months.

Only under medical advice.

No, it is a bile acid therapy.

Yes, liver function monitoring is advised.

• Autoimmune condition

• Body produces little or no insulin

• Requires insulin therapy

• Most common form

• Body does not use insulin effectively

• Managed with oral tablets, injectables, and lifestyle changes

• Occurs during pregnancy

• Requires careful monitoring and treatment

• Lower blood glucose levels

• Improve insulin sensitivity

• Reduce glucose production in the liver

• Reduce glucose production in the liver

• Improve insulin sensitivity

• Stimulate insulin release from the pancreas

• Short-acting insulin secretagogues

Helps maintain fasting and post-meal glucose levels within the target range.

Reduces risk of heart disease, kidney damage, nerve damage, and vision problems.

Enhances the body’s response to insulin.

How Diabetic Medicines Tablets Work:

• Reducing glucose production by the liver

• Increasing insulin secretion from the pancreas

• Improving insulin sensitivity in muscle and fat cells

• Delaying carbohydrate absorption from the intestine

• Type 2 Diabetes Mellitus

• Uncontrolled blood sugar despite diet and exercise

• Combination therapy with insulin

• Prevention of diabetes-related complications

• Patients with insulin resistance

• Adults diagnosed with Type 2 diabetes

• Elderly patients with controlled renal function

• Patients unable to achieve glycemic control with lifestyle changes alone

• Individuals with family history of diabetes

• Store in a cool, dry place

• Protect from moisture and heat

• Keep out of reach of children

• Do not use expired tablets

They are used to control high blood sugar levels in diabetes patients.

Yes, when taken as prescribed by a doctor.

No, they control diabetes but do not permanently cure it.